Found: 13
Select item for more details and to access through your institution.
The role of microfluidics in protein formulations with pre-programmed functional characteristics.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 191, doi. 10.2147/BTT.S126725
- By:
- Publication type:
- Article
Designing of CD8<sup>+</sup> and CD8<sup>+</sup>-overlapped CD4<sup>+</sup> epitope vaccine by targeting late and early proteins of human papillomavirus.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 107, doi. 10.2147/BTT.S177901
- By:
- Publication type:
- Article
Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 127, doi. 10.2147/BTT.S172337
- By:
- Publication type:
- Article
Two decades with omalizumab: what we still have to learn.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 135, doi. 10.2147/BTT.S180846
- By:
- Publication type:
- Article
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 43, doi. 10.2147/BTT.S140114
- By:
- Publication type:
- Article
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn's disease.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 69, doi. 10.2147/BTT.S169326
- By:
- Publication type:
- Article
The conundrum of indeterminate QuantiFERONTB Gold results before anti-tumor necrosis factor initiation.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 61, doi. 10.2147/BTT.S150958
- By:
- Publication type:
- Article
A descriptive analysis of real-world treatment patterns of innovator (Remicade<sup>®</sup>) and biosimilar infliximab in an infliximab-naïve Turkish population.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 97, doi. 10.2147/BTT.S172241
- By:
- Publication type:
- Article
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 75, doi. 10.2147/BTT.S166867
- By:
- Publication type:
- Article
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 11, doi. 10.2147/BTT.S127099
- By:
- Publication type:
- Article
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 37, doi. 10.2147/BTT.S145941
- By:
- Publication type:
- Article
Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 1, doi. 10.2147/BTT.S148606
- By:
- Publication type:
- Article
Analytical characterization of recombinant hCG and comparative studies with reference product.
- Published in:
- Biologics: Targets & Therapy, 2018, v. 12, p. 23, doi. 10.2147/BTT.S141203
- By:
- Publication type:
- Article